Recognizing importance of strengthening US medical supply chains

This Senate Resolution (SR 3) recognizes the need to strengthen U.S. medical supply chains by reducing dependence on China for essential medicines and prioritizing trade with trusted partners like Australia, the EU, Japan, Switzerland, and the UK. It calls on the President to explore policies that decrease reliance on China, preserve tariff-free access to medicines from these partners, and avoid imposing tariffs under Section 232. The resolution specifically urges negotiating bilateral agreements with these countries and maintaining their reciprocal tariff-free treatment. As a non-binding resolution, it directs the President and relevant agencies (Commerce, Trade Representative, National Security Council) to consider these actions but does not create new laws or alter existing policies.